# Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery

Study · id `cardio:ct-nct03838328` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03838328](<https://clinicaltrials.gov/study/NCT03838328>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03838328

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

## Technical summary

Registry record NCT03838328. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-01 (anticipated); primary completion 2020-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 360 participants (planned count; ClinicalTrials.gov record NCT03838328, source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)
- Planned start: 2019-03-01 (anticipated) (ClinicalTrials.gov record NCT03838328, source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)
- Primary completion: 2020-02-28 (anticipated) (ClinicalTrials.gov record NCT03838328, source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)
- Completion: 2020-03-31 (anticipated) (ClinicalTrials.gov record NCT03838328, source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03838328, source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03838328-2019-02-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery
- Condition: Thromboses, Deep Vein
- Condition: Tranexamic Acid Adverse Reaction
- Intervention (Drug): Tranexamic Acid
- Lead sponsor: SHI Jia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)

## Provenance

Content hash: 78f94d36a4346f1c71d121a2d54910cc318ba6b2bfb643bd9747dd7640bd8b90
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
